Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Myalept
Descriptions
Metreleptin injection is used together with a proper diet as replacement therapy to treat problems caused by leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
This medicine is only available under a restricted distribution program called Myalept® REMS program.
This product is available in the following dosage forms:
Portions of this document last updated: Aug. 01, 2020
Copyright © 2020 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.